Receptor Downregulation Findings and Study Design Implications A well-documented finding in the research literature is that continuous IGF-1 receptor activation leads to receptor downregulation after approximately four to six weeks, reducing cellular responsiveness to further stimulation
We projected the health and economic outcomes due to myocardial infarction (MI), stroke, heart failure (HF) and end-stage kidney disease (ESKD) among people with type 2 diabetes, with and without CVD, under scenarios of widespread use of these drugs
Discontinuation rates due to GI side effects ranged from 4-7% across tirzepatide doses in these clinical trials
TZDs improve peripheral insulin sensitivity
Scientific Focus and Experimental Value The scientific value of the KLOW product lies in its ability to bring together multiple peptide systems within a single preparation
Several GLP-1 receptor agonists have shown significant reductions in alcohol consumption in animal models of alcohol addiction